Potential Revolutionary Treatment for Type 1 Diabetes

Preclinical data showcases insulin independence in a diabetic non-human primate post-transplantation of HIP modified islet cells, without immunosuppression. The study by SANA Biotechnologies reveals effective endocrine function of the modified islets, potentially eliminating the need for insulin injections. The research sets a high immunological benchmark by achieving insulin independence and maintaining stable glucose levels in the recipient without any immune reactions. Clinical trials are awaited to further validate the safety and effectiveness of this transformative approach.